Abstract

Targeting ropinirole hydrochloride (R-HCl) to brain in effective amount may be a breakthrough in the treatment of Parkinson's disease due to its extensive first-pass metabolism in stomach after oral administration. The aim of the present investigation was to increase the brain uptake of R-HCl through chitosan nanoparticles prepared by conventional emulsification crosslinking method. The drug encapsulation efficiency (%), particle size, polydispersity index and zeta potential of polysorbate 80 coated R-HCl loaded chitosan nanoparticles were found satisfactory. These coated nanoparticles were characterized by SEM, FTIR and DSC analyses. In vitro drug release from different uncoated and coated chitosan nanoparticles showed initial burst release of R-HCl followed by a sustained release over 10 h. The coated nanoparticles were found stable over 3 months storage. In vivo biodistribution studies in Wistar rats exhibited higher R-HCl concentrations in brain with less accumulations of R-HCl in liver, spleen and kidney for polysorbate 80 coated R-HCl loaded chitosan nanoparticles after 1 h of dose administration (i.v.) as compared to these of uncoated R-HCl loaded chitosan nanoparticles and pure R-HCl. These observations suggested that the surface coated R-HCl loaded chitosan nanoparticles could be a useful tool to improve brain accumulation of R-HCl.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.